This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lundy, S. K. Articles by Lukacs, N. W. Search for Related Content PubMed PubMed Citation Articles by Lundy, S. K. Articles by Lukacs, N. W.

(American Journal of Pathology. 2003;163:1961-1968.)
© 2003 American Society for Investigative Pathology

Interleukin-12-Independent Down-Modulation of Cockroach Antigen-Induced Asthma in Mice by Intranasal Exposure to Bacterial Lipopolysaccharide

From the Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan

Several studies have shown that exposure to bacterial lipopolysaccharide (LPS) can either prevent or inhibit asthma in humans and laboratory rodents. Much emphasis has been placed on the role of cytokines and chemokines in the establishment and maintenance of allergic airway disease. Therefore, it is of interest to study the role of LPS in affecting airway pathology and lung cytokine and chemokine responses in the maintenance phase of asthma. Increasing doses of LPS were administered into the airways of mice presensitized with cockroach allergen (CRAg), then allergic airway disease parameters were assessed after CRAg challenge. Airway hyperresponsiveness after antigen challenge decreased at the highest dose of LPS tested, which was accompanied by a decrease in airway and lung eosinophils. However, a dramatic increase in lung inflammation because of neutrophil influx was observed. Measurement of cytokines in lungs of LPS-treated, CRAg-sensitized mice indicated that interleukin (IL)-12 levels were increased by LPS treatment in a dose-dependent manner, as were levels of several inflammatory chemokines. In contrast, levels of IL-4, IL-13, IL-5, and IL-10 were reduced in whole lung homogenates only of high-dose LPS-treated mice. Intranasal administration of neutralizing anti-IL-12 at the time of high-dose LPS challenge reduced lung IL-12, interferon-, CXCL9, and CXCL10 but did not affect levels of the other chemokines or Th2-type cytokines, and did not restore AHR. These findings suggest that the amelioration of airway hyperresponsiveness observed in LPS-treated, CRAg-sensitized mice is coincident with an immune deviation of the lung inflammatory response, independent of IL-12.

This article has been cited by other articles:

				J. Douwes and N. Pearce Commentary: The end of the hygiene hypothesis? Int. J. Epidemiol., June 1, 2008; 37(3): 570 - 572. [Full Text] [PDF]

				R. S. Pero, M. T. Borchers, K. Spicher, S. I. Ochkur, L. Sikora, S. P. Rao, H. Abdala-Valencia, K. R. O'Neill, H. Shen, M. P. McGarry, et al. G{alpha}i2-mediated signaling events in the endothelium are involved in controlling leukocyte extravasation PNAS, March 13, 2007; 104(11): 4371 - 4376. [Abstract] [Full Text] [PDF]

				Y. W. Jung, T. R. Schoeb, C. T. Weaver, and D. D. Chaplin Antigen and Lipopolysaccharide Play Synergistic Roles in the Effector Phase of Airway Inflammation in Mice Am. J. Pathol., May 1, 2006; 168(5): 1425 - 1434. [Abstract] [Full Text] [PDF]

				M. Kaviratne, M. Hesse, M. Leusink, A. W. Cheever, S. J. Davies, J. H. McKerrow, L. M. Wakefield, J. J. Letterio, and T. A. Wynn IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-{beta} Independent J. Immunol., September 15, 2004; 173(6): 4020 - 4029. [Abstract] [Full Text] [PDF]